Literature DB >> 11906464

Garlic and its active metabolite allicin produce endothelium- and nitric oxide-dependent relaxation in rat pulmonary arteries.

David D Ku1, Tarek T Abdel-Razek, Jun Dai, SangAe Kim-Park, Michael B Fallon, Gary A Abrams.   

Abstract

1. The aims of the present study were to investigate the effects of fresh garlic and one of its active metabolites, allicin, on rat isolated pulmonary arteries (RPA). 2. In endothelium-intact and phenylephrine-precontracted RPA, the addition of a water or a 5% ethanol extract of fresh garlic (1-500 microg/mL) resulted in a dose-dependent relaxation reaching a maximum (mean +/- SEM) of -91 +/- 3 and -93 +/- 2%, respectively, with an ED(50) of 113 +/- 12 and 106 +/- 10 microg/mL, respectively. The vasorelaxation was readily reversible upon washing and no tachyphylaxis was noted. 3. An extract of the external garlic storage leaf produced a significantly greater relaxation than the inner stem. Microfiltration of extracts with a 10,000 molecular sieve did not attenuate relaxation. Inactivation of alliinase and allicin formation, with either boiling of the garlic clove for 30 min or 100% ethanol treatment, completely abolished relaxation. In contrast, similar treatment of crushed garlic with formed allicin retained the relaxation response. 4. Pure allicin produced a similar relaxation as garlic extract, with an EC(50) of approximately 0.8 microg/mL. Disruption of endothelium or N(G)-nitro-L-arginine methyl ester pretreatment attenuated the relaxation, whereas indomethacin had no effect. 5. Prior garlic (500 microg/mL) treatment enhanced acetylcholine relaxation by shifting the response curve to the left, but had no effect on nitric oxide (NO) donor-induced responses. 6. These results demonstrate that garlic and the active metabolite allicin are capable of eliciting a NO-dependent relaxation in RPA and that this response is likely to be mediated via garlic activation of NO formation rather than its stabilization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906464     DOI: 10.1046/j.1440-1681.2002.03596.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  14 in total

Review 1.  A review on the effects of Allium sativum (Garlic) in metabolic syndrome.

Authors:  A Hosseini; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2015-06-03       Impact factor: 4.256

2.  A rethinking on the benefits and drawbacks of common antioxidants and a proposal to look for the antioxidants in allium products as ideal agents: a review.

Authors:  K T Augusti; Regi Jose; G R Sajitha; Paul Augustine
Journal:  Indian J Clin Biochem       Date:  2011-08-09

3.  Effect of oral garlic on arterial oxygen pressure in children with hepatopulmonary syndrome.

Authors:  Mehri Najafi Sani; Hamid-Reza Kianifar; Abdolrazagh Kianee; Gholamreza Khatami
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

5.  Garlic compound, diallyl disulfide induces cell cycle arrest in prostate cancer cell line PC-3.

Authors:  Arumugam Arunkumar; Marati Radhakrishnan Vijayababu; Narasimman Srinivasan; Maria Michael Aruldhas; Jagedeesan Arunakaran
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

6.  Hydrogen sulfide mediates the vasoactivity of garlic.

Authors:  Gloria A Benavides; Giuseppe L Squadrito; Robert W Mills; Hetal D Patel; T Scott Isbell; Rakesh P Patel; Victor M Darley-Usmar; Jeannette E Doeller; David W Kraus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-19       Impact factor: 11.205

7.  Effects of allitridum on the transient outward potassium current in rats with heart failure.

Authors:  Xiao-Jing Zhao; Kun Lin; Yu Zhang; Bin Xu; Li Liu; Yi-Cheng Fu; Xi Chen; Zhong-Qi Cai; Zhi-Juan Wu; Yun Huang; Yang Li
Journal:  J Geriatr Cardiol       Date:  2016-09       Impact factor: 3.327

Review 8.  Pharmacological treatment for hepatopulmonary syndrome.

Authors:  Ahad Eshraghian; Amir A'lam Kamyab; Seung Kew Yoon
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

9.  Transition from hepatopulmonary syndrome to portopulmonary hypertension: a case series of 3 patients.

Authors:  Radhika Zopey; Irawan Susanto; Igor Barjaktarevic; Tisha Wang
Journal:  Case Rep Pulmonol       Date:  2013-11-10

Review 10.  Anti-hypertensive Herbs and their Mechanisms of Action: Part I.

Authors:  Sara S Al Disi; M Akhtar Anwar; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-01-19       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.